NASDAQ$LMAT
LeMaitre Vascular Inc · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
LeMaitre Vascular reported Q1 2026 net sales of $66.6M and net income of $15.7M, or $0.68 diluted EPS.
For the quarter ended March 31, 2026, LeMaitre posted net sales of $66.6 million, up 11% from $59.9 million a year ago, with broad growth across vascular device lines. Net income was $15.7 million, or $0.68 per diluted share, versus $11.0 million and $0.48 in Q1 2025.
- Net sales $66.6M (+11% YoY).
- Gross profit $48.4M; operating income $17.8M.
- Net income $15.7M; EPS $0.68.
- International and OEM channels contributed.
Headline financials
Revenue & EPS history
LeMaitre Vascular · Revenue · Quarterly
$66.6M
Forward guidance
Procedure volumes, hospital capital budgets, and tuck-in M&A support medium-term growth targets.
Tailwinds
- Consistent double-digit sales growth.
- High margin medical device profile.
Headwinds
- Small cap sensitive to hospital spending cycles.
- FX on international sales.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2026
+1.2%
Avg return
Earnings day
+0.7%
Avg return
5 days after
+1.5%
Avg return
30 days after
52%
34 / 65 earnings
Positive
+24.3%
Q1 2017
Best reaction
-22.1%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.6% | -9.3% | -15.7% | |
| Q4 2025 | +24.2% | +18.0% | +16.7% | |
| Q3 2025 | +1.4% | +5.1% | -1.2% | |
| Q1 2025 | -13.0% | -9.6% | -8.9% | |
| Q4 2024 | -8.1% | -12.9% | -16.9% | |
| Q3 2024 | +6.5% | +10.8% | +20.1% | |
| Q2 2024 | -2.2% | -5.8% | +3.9% | |
| Q1 2024 | +11.1% | +13.7% | +18.1% | |
| Q4 2023 | +15.2% | +9.5% | +7.6% | |
| Q3 2023 | -4.0% | +1.3% | +10.8% | |
| Q2 2023 | +2.3% | -10.1% | -8.6% | |
| Q1 2023 | +15.4% | +23.6% | +17.1% | |
| Q4 2022 | +6.2% | +3.7% | +5.2% | |
| Q3 2022 | -19.6% | -17.4% | -11.5% | |
| Q2 2022 | +4.7% | +7.1% | +3.8% | |
| Q1 2022 | -2.9% | -0.2% | +2.6% | |
| Q4 2021 | +6.2% | +9.1% | +3.0% | |
| Q3 2021 | -5.2% | -3.9% | -11.2% | |
| Q2 2021 | -0.5% | +2.3% | +2.9% | |
| Q1 2021 | -2.8% | -4.9% | -5.1% | |
| Q4 2020 | +7.8% | +7.8% | -2.0% | |
| Q3 2020 | -1.7% | +5.6% | +19.8% | |
| Q2 2020 | +13.3% | +4.4% | +3.9% | |
| Q1 2020 | -14.1% | -14.9% | -12.4% | |
| Q4 2019 | -20.1% | -20.0% | -23.6% | |
| Q3 2019 | -1.5% | +0.8% | +1.8% | |
| Q2 2019 | +0.8% | +1.0% | -4.4% | |
| Q1 2019 | -8.2% | -4.1% | -10.6% | |
| Q4 2018 | +22.3% | +18.0% | +24.3% | |
| Q3 2018 | -22.1% | -27.3% | -25.8% | |
| Q2 2018 | -7.1% | -3.6% | -4.5% | |
| Q1 2018 | -16.6% | -18.9% | -16.2% | |
| Q4 2017 | +1.6% | +0.4% | +0.9% | |
| Q3 2017 | -17.7% | -15.7% | -8.2% | |
| Q2 2017 | +17.4% | +19.2% | +17.9% | |
| Q1 2017 | +24.3% | +18.5% | +17.9% | |
| Q4 2016 | -6.9% | -6.8% | +1.3% | |
| Q3 2016 | +9.4% | +8.6% | +24.9% | |
| Q2 2016 | +15.1% | +24.1% | +21.4% | |
| Q1 2016 | -1.4% | — | — | |
| Q4 2015 | +18.5% | — | — | |
| Q3 2015 | +11.0% | — | — | |
| Q2 2015 | +14.0% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | +2.2% | — | — | |
| Q3 2014 | +3.0% | — | — | |
| Q2 2014 | +3.5% | — | — | |
| Q1 2014 | +4.6% | — | — | |
| Q4 2013 | -2.2% | — | — | |
| Q3 2013 | -1.4% | — | — | |
| Q2 2013 | +1.2% | — | — | |
| Q1 2013 | +1.5% | — | — | |
| Q4 2012 | +3.3% | — | — | |
| Q3 2012 | -0.6% | — | — | |
| Q2 2012 | +1.6% | — | — | |
| Q1 2012 | +0.3% | — | — | |
| Q4 2009 | -1.2% | — | — | |
| Q4 2011 | -1.2% | — | — | |
| Q3 2010 | -1.9% | — | — | |
| Q3 2011 | -1.9% | — | — | |
| Q4 2010 | +0.1% | — | — | |
| Q2 2011 | +0.1% | — | — | |
| Q2 2010 | +0.1% | — | — | |
| Q1 2011 | -1.1% | — | — | |
| Q1 2010 | -3.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro